The Kirby Institute Postgraduate Student Prize is an annual award given to the most significant first author paper by a Kirby Institute student, published in the previous calendar year in a peer-reviewed journal in the area of infectious diseases.
*Please note this is a hybrid seminar with registration options for in-person and online attendance. Lunch will be provided from 12:30pm for in-person attendees, with the seminar to follow at 1pm.
Integrase Strand Transfer Inhibitor–Related Changes in Body Mass Index and Risk of Diabetes: A Prospective Study From the RESPOND Cohort Consortium
Dhanushi's talk will focus on Integrase Strand Transfer Inhibitors (INSTI), which are effective in HIV suppression but have been linked to weight gain and increased risk of diabetes (DM). Using a large cohort from Europe and Australia, analysis has shown that current INSTI use was independently associated with incident DM, even when compared to other ART regimens like PIs and NNRTIs. Lack of interaction between BMI and DM risk, suggested INSTIs may elevate DM risk regardless of weight gain.
| Senior Research Associate, HIV Epidemiology and Prevention Program, Kirby Institute
Dr Dhanushi Rupasinghe is a biostatistician working on ACCESS (Australian Collaboration for Coordinated Enhanced Sentinel Surveillance) cohort. She is currently a Senior Research Associate in the HIV Epidemiology and Prevention Program at the Kirby Institute, UNSW Sydney. She has experience in analysing large HIV observational cohorts (AHOD, RESPOND, TAHOD, TAHOD-CC, TAHOD-LITE), multi-regional epidemiological datasets and prior experience working on genetic-linkage studies. Dhanushi’s research interests and experience include observational cohorts in HIV, liver, and diabetes. |
Opinions expressed in the Kirby Institute Seminar Series are solely those of the speaker and do not necessarily represent the views or opinions of the Kirby Institute or UNSW.